Do You Know Why Clot Contracts? Marin Pavlov Reflects on Expert PE Conference 2025
Marin Pavlov, Assistant Professor at Sveučilište Sjever / University North, shared on LinkedIn:
”Hey clot bros,
Do you know why clot contracts?
What are the viscoelastic properties of thrombi in pts with recidive as opposed to pts with first vte episode?
What is Khorana score? How relevant is VTE incidence in the first pregnancy trimester?
How Catalin Toma tackles proximal DVT in PE patients scheduled for intervention and clots in transit?
What were the results of 6mw tests in Storm PE? When to expect HI-PEITHO results?
How is recruitment going for PEERLESS II and PERSEVERE? What does Stefano Barco have to suggest for your ECMO PE cases?
What do James Horowitz and our transatlantic friends do to promote VTE awareness?
Third edition of Expert PE conference in beautiful city of Krakow delivered superb lectures, vibrant discussions, and insight in what clinicians and researches are doing in centers of excelence.
A general take home message might be that we not only need more studies, but we need to study more this highly relevant, yet heterogenic and peculiar disease.
ACVC_ESC was represented by Agnieszka Tycińska MD, PhD, FESC and Ingo Ahrens, while the meeting was endorsed by ACVC.
Sincere congratulations to Expert PE study group members and enthusiastic Polish cardiac society.”
Stay updated with Hemostasis Today.
-
Nov 24, 2025, 10:25Jean Jacques Kiladjian Visits INSERM-supervised CIC 1408 Investigation Center
-
Nov 24, 2025, 10:06Amirpasha Moetazedian Invites a PHD Student to His Lab to Explore Sustainable Artificial Blood Vessels
-
Nov 24, 2025, 09:41Kamran Hajiyev Reflects on A Week of Innovation, Collaboration, and Scientific Exchange at SVIN 2025
-
Nov 24, 2025, 01:39Ashkan Shoamanesh Shares OCEANIC-STROKE Trial’s Successful Endpoints
-
Nov 24, 2025, 01:10Swarsat K Nath on HemeNext 2025: AI is Real, Measurable, and Already Changing Lives
-
Nov 23, 2025, 15:15Dirk Sibbing on OCEANIC-STROKE Demonstrationg Superiority of Asundexian vs. Placebo
-
Nov 23, 2025, 14:57Jesse Landry on SeraGene Therapeutics: Rewriting the Rules of Blood and Bleeding Disorders
-
Nov 23, 2025, 14:49Reza Shojaei: What Truly Motivates Donors And What Keeps Them Coming Back?
-
Nov 23, 2025, 14:48Michael Davidson: Why LDL Alone Isn’t Enough for CV Risk Reduction